Navigation Links
RapidX250 Rapid Prototype Tool for Micro Fabrication of Microfluidics, MEMs and Medical Devices
Date:8/3/2011

NASHUA, N.H., Aug. 3, 2011 /PRNewswire/ -- Resonetics introduces the RapidX250 laser micromachining system, developed for Universities and Corporate research to fabricate microfluidics, MEMs and medical devices in a rapid prototype fashion with tolerances approaching 1 micron. Traditionally MEMs devices are fabricated by traditional semiconductor lithography but the multi-step process takes significant time. The RapidX250 uses a multi-wavelength excimer laser (193nm and 248nm) to directly fabricate the structures in a single step, drastically reducing prototype time.

(Photo:  http://photos.prnewswire.com/prnh/20110803/NE46107 )

Compared with other lasers and methods, the RapidX250 is very flexible, able to micro fabricate 2-D (flat sheets, tubes) and 3-D parts (balloons, non-planar surfaces) , including XYZ, theta and goniometer. At 193nm laser wavelength, the laser can ablate cleanly fluropolymers (such as nylon, pebax, Teflon), bioabsorbable polymers and glass. The system has a quick exchange scheme to allow the user to switch to 248nm laser wavelength, ideal for machining polymers, ceramic and metals (such as stents)

And lastly the RapidX250 was designed to be user friendly with a DXF file-to-CNC converter to quickly convert concepts into prototypes, ideal for a multi-user environment

About Resonetics LLC:

Resonetics is the largest total solution provider of laser micromachining products and services in the world. It is also regarded as having the largest independent plastic (polymer) laser micromachining facility with more than 50 UV-based laser micromachining systems and with three clean rooms.

Laser micromachining represents a critical fabrication technology for the manufacturing of medical devices, diagnostics, and a variety of non-medical products as the machining features become increasingly small.

The US-based company has three
'/>"/>

SOURCE Resonetics LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Avantra Biosciences Announces the Launch of a Rapid Assay Prototyping Service
2. Novel ACR Hybrid Score in Rheumatoid Arthritis Applied for the First Time to Data from the RAPID 1 Study with Cimzia® (certolizumab pegol)
3. Rapid etching X-rayed
4. Quest Diagnostics to Acquire Athena Diagnostics, Establishing Leading Position in Rapidly Growing Neurology Testing Market
5. BD Expands Industrial Microbiology Rapid Methods Portfolio
6. Neogens Rapid Test for Salmonella enteritidis Receives FDA Approval
7. Prince of Wales Hospital in Hong Kong First in Asia to Offer Cancer Patients Image-Guided RapidArc® Radiotherapy Using the UNIQUE™ Radiotherapy System
8. Neogens Rapid Test for Salmonella enteritidis Receives AOAC Approval
9. Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry
10. Precision Therapeutics Growing Rapidly as it Augments Research and Development Efforts
11. Rapid Increase in the Number of Worldwide Nanotechnology Degree Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... (PRWEB) August 19, 2014 Robin Williams’ ... disease can take on an individual. Symptoms range ... facial expression, problems swallowing and severe depression. Parkinson’s ... dying off of dopamine producing neurons of the brain. ... a disease that slowly and progressively gets worse, they ...
(Date:8/19/2014)... In November 2012, the European Union (EU) ... (PBRER) in a new PSUR – responding to the increasing ... of a drug. Adopted in many regions, the main objectives ... a comprehensive and critical analysis of new or emerging information ... any new evidence of the potential benefits of a drug; ...
(Date:8/18/2014)... August 19, 2014 2014 Deep ... is a professional and in-depth research report on ... Linalool information, including its definition, classification, application, ... overview. This research covers the international market analysis, ... industry analysis covering macroeconomic environment & economic situation ...
(Date:8/18/2014)... Sterne, Kessler, Goldstein & Fox P.L.L.C. , an intellectual ... , announced today that it has filed eleven petitions ... U.S. Patent and Trademark Office (USPTO) on behalf of ... BRLI).  These IPR petitions aim to nullify eleven patents ... patents have been asserted against GeneDx in patent infringement ...
Breaking Biology Technology:As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 2As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 3Top Five Best Practices for Developing Your Periodic Benefit Risk Evaluation Report (PBRER), New Webinar Hosted by Xtalks 2Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 2Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 3Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 4Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 2Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 3
... AtheroNova Inc. (OTCBB: AHRO) ("AtheroNova"), a biotech company ... to regress atherosclerotic plaque, announced the recent presentation ... Division of Cardiology at the David Geffen School ... Heart Association (AHA) Scientific Sessions in Orlando, Florida.  ...
... 2011  If algae is to be the solution for America,s ... make that a reality. Applications are now available for continuing ... retrain workers as general science technicians in the rapidly expanding ... Approximately 55 students will begin classes in ...
... 22, 2011 Sequenom, Inc. (NASDAQ: SQNM ), ... announced the Company,s participation at the 23rd Annual Piper Jaffray ... November 29-30, 2011. Ronald M. Lindsay, Ph.D., ... Maier, CFO, will present on Tuesday, November 29, 2011 beginning ...
Cached Biology Technology:AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation 2Free Job Training: 55 Grants Available to Retrain Workers for Biofuels Industry 2Free Job Training: 55 Grants Available to Retrain Workers for Biofuels Industry 3Sequenom Announces Participation at the 23rd Annual Piper Jaffray Healthcare Conference 2
(Date:8/19/2014)... crocodiles colonised the seas during warm phases and became ... study which establishes a link between marine crocodilian diversity ... of more than 140 million years. , The ... de Lyon, France and formerly from the University of ... Communications ., Today, crocodiles are ,cold-blooded, animals that mainly ...
(Date:8/19/2014)... The University of Texas Health Science Center at San ... (UTSA) today announced the awarding of more than $750,000 ... (SALSI) Innovation Challenge. , Launched in 2003, SALSI is ... and an academic health science center join forces for ... funds collaborative studies, with a focus on public health ...
(Date:8/19/2014)... has been awarded a nearly $40,000 grant from the ... office of the National Park Service (NPS) and U.S. ... one-year study of the energy efficiency and cost effectiveness ... humid climates. , Radiant barriers are reflective thermal insulations ... back, thereby reducing the amount of heat emitted in ...
Breaking Biology News(10 mins):Evolution of marine crocodilians constrained by ocean temperatures 2San Antonio Life Sciences Institute awards $750,000 to innovators 2San Antonio Life Sciences Institute awards $750,000 to innovators 3UTSA researcher awarded $38K+ to evaluate energy efficiency options for historic homes 2UTSA researcher awarded $38K+ to evaluate energy efficiency options for historic homes 3
... vegetative cover, strong winds, dry, non-cohesive sandy soils, ... resources of Abu Dhabi Emirate in the United ... stresses, including wind erosion, salinization, waterlogging, landfilling, and ... Dhabi Emirate, land degradation is a matter of ...
... have found a way to save time, money and ... shed light on the biological processes associated with all ... genetics, and postdoctoral associate Matthew C. Hale have provided ... necessary with recent advances in DNA sequencing technology. Instead, ...
... Pfizer Inc., a major biopharmaceutical company, and the Wisconsin ... licensing organization for the University of Wisconsin-Madison, announced May ... embryonic stem (hES) cell patents for the development of ... the rights to work with hES cells for drug ...
Cached Biology News:Wind, salt and water are leading indicators of land degradation in Abu Dhabi 2Random picks better than complicated process in gene identification 2WARF signs license agreement with Pfizer for human embryonic stem cells 2
... bioassays for interferons are cytopathic effect inhibition assays, ... Sample types include; tissue culture supernatents; serum from ... assays, one unit is defined as the quantity ... cytopathic effect of viral infection by 50%. ...
... cytopathic effect inhibition assays, also known as CPE ... culture supernatents; serum from PK studies and delivery ... defined as the quantity of interferon required per ... infection by 50%. All standards used ...
... bioassays for interferons are cytopathic effect inhibition assays, ... Sample types include; tissue culture supernatents; serum from ... assays, one unit is defined as the quantity ... cytopathic effect of viral infection by 50%. ...
...
Biology Products: